March 27th 2024
For most patients younger than age 60 with polycythemia vera (PV) who are not considered high risk, cytoreductive therapies are withheld despite being highly effective.
A statement from NCCN’s Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis said that the panel “endorses vaccination for all eligible persons based on FDA-approved indications or emergency use authorization” and emphasized the need for everyone to be fully vaccinated—including third doses.
Read More
Dr Peter Hotez on Combatting Antivaccination Beliefs and Rescuing Public Health From Politics
December 21st 2021In an interview conducted before the highly transmissible Omicron coronavirus variant began driving another wave of infections, Peter Hotez, MD, PhD, FASTMH, discussed the struggle public health officials and scientists have in fighting false beliefs about vaccinations.
Watch
Stronger Community Connections, Fewer Barriers Are Keys to Better Trials
December 19th 2021Bruce A. Feinberg, DO, of Cardinal Health Specialty Solutions, leads a panel discussion on how far randomized clinical trials have come, how they could be better, and how using real-world evidence could make research more representative of the population.
Read More
Using AI to Detect Early Signs of Parkinson Disease Through Facial Analysis
December 11th 2021Researchers at the University of Rochester are analyzing facial muscle movements through videos taken over webcams or smartphones to train a machine learning algorithm with the hope that it can predict Parkinson disease at an earlier stage.
Read More
Review Suggests Having IBD May Increase Risk of PD
December 1st 2021The meta-analysis sought to clarify previous research, which has explored the idea that Parkinson disease (PD) is tied to inflammation in the gastrointestinal tract, noting that inflammatory bowel disease (IBD) has been implicated in neuroinflammation.
Read More
ASOPRS Fall Symposium Will Feature Innovations, Diversity, and Diet Presentations
November 9th 2021The American Society of Ophthalmic Plastic & Reconstructive Surgery 2021 Fall Scientific Symposium will feature presentations on oculofacial surgery innovations, social justice and diversity, and more.
Read More
To Prevent the Next Pandemic, Fight Antiscience Beliefs, Hotez Says
November 7th 2021While low- and middle-income countries remain desperate for a COVID-19 vaccine, the United States has entered a dangerous new phase of the pandemic, where antivaccine forces are exporting their antiscience beliefs to other countries, according to a keynote speaker at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Read More
Dr Carina Venter on the Gut Microbiome’s Role in Allergic Disease
November 7th 2021Carina Venter, PhD, RD, allergy specialist dietitian and associate professor in pediatric allergy and immunology at Children's Hospital Colorado and the University of Colorado, discusses the gut microbiome’s complex relationship with our immune system and diet diversity’s potential role in allergic disease and food allergy–related outcomes.
Watch
Patients With CTEPH Have Worse Baseline HRQOL Than Patients With IPAH
November 6th 2021At baseline, patients with chronic thromboembolic pulmonary hypertension (CTEPH) had worse health-related quality of life (HRQOL) than patients with idiopathic pulmonary arterial hypertension (IPAH), but over time the scores were similar.
Read More
More SMA Biomarkers Are Needed to Gauge Disease Progression, Therapy Response
October 21st 2021A review of current molecular and electrophysiological biomarkers in spinal muscular atrophy (SMA) concluded that more exploration is necessary to find noninvasive, yet accurate, measures of disease progression and therapy response.
Read More
Dr Don Sin on the Barriers to Precision Medicine for COPD
October 18th 2021There are several reasons as to why precision therapeutics have not taken off for chronic obstructive pulmonary disease (COPD) in the same way that they have for other diseases, said Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital.
Watch
Patient Characteristics Impact Effectiveness of TKIs in CML and AEs Experienced
October 1st 2021Dosing from pivotal phase 3 trials of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) is not optimal for real-world patients who experience different efficacy and adverse events (AEs).
Read More
Addressing Disparities Starts With Engaging the Community
September 24th 2021In the opening sessions at the Patient-Centered Oncology Care® conference, held September 23-24 both virtually and in Nashville, Tennessee, speakers focused on addressing disparities by getting involved and engaged with the community.
Read More
Reducing Disparities, Using AI, Improving Clinical Trials on Tap for PCOC 2021
September 17th 2021At the 10th anniversary meeting of Patient-Centered Oncology Care®, sessions will cover reducing disparities in cancer care, bringing clinical trials closer to the community, and expanding the scope of what the term "precision medicine" means in cancer care.
Read More
Could Psychedelics Ease Mental Health Toll From COVID-19, Other Crises?
September 15th 2021The fallout from COVID-19 has spotlighted the limitations of US mental health care, prompting the question if alternative treatments—like psychedelics—could help address current and impending crises.
Read More